Oncology Central

Impact of a shortened surveillance interval on hepatocellular carcinoma survival


The surveillance of hepatocellular carcinoma (HCC), which has been a standard of care in the management of patients with chronic liver diseases, greatly contributed to the early detection of liver cancers amenable to curative treatment. Nonetheless, the current strategy for HCC surveillance does not seem to be ideal and the problems may mostly arise from the incompleteness of surveillance tools. As revealed by a study using the cohort of the HALT-C trial, the most common reason for identifying HCC at a late stage was an absence of detection despite adherence to surveillance, which clearly implies that better surveillance tools are required [1].

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.